Jean‐Roch Fabreguettes

Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction

Philippe Menasché, Valérie Vanneaux, Albert Hagège et al. · Journal of the American College of Cardiology · 2018 · 435 citations

Regenerative Medicine, Heart Failure, Developmental Biology +14

Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report: Figure 1

Philippe Menasché, Valérie Vanneaux, Albert Hagège et al. · European Heart Journal · 2015 · 427 citations · Full text

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial

Gabriella Marcon, Alain Mallet, Mauro Tettamanti et al. · The Lancet Neurology · 2014 · 200 citations

Creutzfeldt-jakob Disease, Medicine, Placebo-controlled Trial +4

Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience

Philippe Menasché, Valérie Vanneaux, Jean‐Roch Fabreguettes et al. · European Heart Journal · 2014 · 167 citations · Full text

Successful treatment of congenital hyperinsulinism with long-acting release octreotide

Kim‐Hanh Le Quan Sang, Jean‐Baptiste Arnoux, Asmaa Mamoune et al. · European Journal of Endocrinology · 2011 · 88 citations · Full text